Dr. Esen Akpek, M.D

NPI: 1851356943
Total Payments
$627,113
2024 Payments
$188,970
Companies
20
Transactions
239
Medicare Patients
4,326
Medicare Billing
$506,105

Payment Breakdown by Category

Consulting$561,919 (89.6%)
Travel$27,184 (4.3%)
Other$27,000 (4.3%)
Research$6,953 (1.1%)
Food & Beverage$3,932 (0.6%)
Education$126.40 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $561,919 75 89.6%
Travel and Lodging $27,184 74 4.3%
Grant $22,500 2 3.6%
Unspecified $6,953 9 1.1%
Honoraria $4,500 5 0.7%
Food and Beverage $3,932 73 0.6%
Education $126.40 1 0.0%

Payments by Type

General
$620,160
230 transactions
Research
$6,953
9 transactions

Top Paying Companies

Company Total Records Latest Year
W. L. Gore & Associates, Inc. $470,876 132 $0 (2024)
Regeneron Pharmaceuticals, Inc. $55,518 42 $0 (2024)
Shire North American Group Inc $19,921 21 $0 (2018)
Bausch & Lomb, a division of Bausch Health US, LLC $15,000 1 $0 (2021)
Dompe US, Inc. $13,313 11 $0 (2024)
Bausch & Lomb Americas Inc. $11,054 7 $0 (2024)
Otsuka Pharmaceutical Development & Commercialization, Inc. $9,210 2 $0 (2024)
GENZYME CORPORATION $6,448 4 $0 (2017)
Alcon Vision LLC $6,052 3 $0 (2024)
Mallinckrodt Hospital Products Inc. $3,700 2 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $188,970 73 W. L. Gore & Associates, Inc. ($163,864)
2023 $16,529 10 Dompe US, Inc. ($9,188)
2022 $10,337 14 Bausch & Lomb Americas Inc. ($8,950)
2021 $23,706 32 Bausch & Lomb, a division of Bausch Health US, LLC ($15,000)
2020 $96,703 29 W. L. Gore & Associates, Inc. ($70,475)
2019 $49,760 29 W. L. Gore & Associates, Inc. ($33,806)
2018 $207,658 25 W. L. Gore & Associates, Inc. ($196,444)
2017 $33,450 27 Regeneron Pharmaceuticals, Inc. ($15,588)

All Payment Transactions

239 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
12/20/2024 W. L. Gore & Associates, Inc. Product in Development (Device) Consulting Fee Cash or cash equivalent $32,000.00 General
Category: Devices
12/16/2024 Alcon Vision LLC Consulting Fee Cash or cash equivalent $4,000.00 General
12/16/2024 W. L. Gore & Associates, Inc. Product in Development (Device) Travel and Lodging In-kind items and services $179.76 General
Category: Devices
11/22/2024 W. L. Gore & Associates, Inc. Product in Development (Device) Consulting Fee Cash or cash equivalent $12,000.00 General
Category: Devices
11/22/2024 W. L. Gore & Associates, Inc. Product in Development (Device) Consulting Fee Cash or cash equivalent $8,000.00 General
Category: Devices
11/22/2024 W. L. Gore & Associates, Inc. Product in Development (Device) Consulting Fee Cash or cash equivalent $4,800.00 General
Category: Devices
11/22/2024 W. L. Gore & Associates, Inc. Product in Development (Device) Consulting Fee Cash or cash equivalent $4,000.00 General
Category: Devices
11/22/2024 W. L. Gore & Associates, Inc. Product in Development (Device) Consulting Fee Cash or cash equivalent $3,200.00 General
Category: Devices
11/14/2024 W. L. Gore & Associates, Inc. Product in Development (Device) Travel and Lodging In-kind items and services $427.97 General
Category: Devices
11/13/2024 W. L. Gore & Associates, Inc. Product in Development (Device) Travel and Lodging In-kind items and services $358.96 General
Category: Devices
11/08/2024 W. L. Gore & Associates, Inc. Product in Development (Device) Consulting Fee Cash or cash equivalent $16,000.00 General
Category: Devices
11/08/2024 W. L. Gore & Associates, Inc. Product in Development (Device) Consulting Fee Cash or cash equivalent $8,000.00 General
Category: Devices
11/08/2024 W. L. Gore & Associates, Inc. Product in Development (Device) Consulting Fee Cash or cash equivalent $6,400.00 General
Category: Devices
11/08/2024 W. L. Gore & Associates, Inc. Product in Development (Device) Consulting Fee Cash or cash equivalent $1,600.00 General
Category: Devices
11/07/2024 Alcon Vision LLC Consulting Fee Cash or cash equivalent $2,000.00 General
11/05/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $1,075.00 General
10/31/2024 Bausch & Lomb Americas Inc. XIIDRA (Drug), MIEBO Food and Beverage In-kind items and services $143.53 General
Category: Ophthalmology
10/31/2024 Bausch & Lomb Americas Inc. XIIDRA (Drug), MIEBO Travel and Lodging In-kind items and services $56.11 General
Category: Ophthalmology
10/28/2024 W. L. Gore & Associates, Inc. Product in Development (Device) Food and Beverage In-kind items and services $55.72 General
Category: Devices
10/23/2024 W. L. Gore & Associates, Inc. Product in Development (Device) Food and Beverage In-kind items and services $96.97 General
Category: Devices
10/20/2024 W. L. Gore & Associates, Inc. Product in Development (Device) Food and Beverage In-kind items and services $78.34 General
Category: Devices
10/18/2024 Bausch & Lomb Americas Inc. Food and Beverage In-kind items and services $130.17 General
10/11/2024 W. L. Gore & Associates, Inc. Product in Development (Device) Travel and Lodging In-kind items and services $179.40 General
Category: Devices
10/11/2024 W. L. Gore & Associates, Inc. Product in Development (Device) Food and Beverage In-kind items and services $39.02 General
Category: Devices
10/10/2024 W. L. Gore & Associates, Inc. Product in Development (Device) Food and Beverage In-kind items and services $49.47 General
Category: Devices

Research Studies & Clinical Trials

Study Name Company Amount Records
DUPIXENT CLINICAL DEVELOPMENT PROGRAM Regeneron Pharmaceuticals, Inc. $2,940 4
OBSERVATIONAL STUDY OF CONJUNCTIVITIS IN THE SETTING OF DUPIXENT TREATMENT FOR ATOPIC DERMATITIS Regeneron Pharmaceuticals, Inc. $2,873 4
BAWH_KSI KOWA COMPANY, LTD. $1,140 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 18 1,089 1,341 $637,215 $139,364
2022 18 1,224 1,489 $544,436 $141,744
2021 18 1,210 1,447 $498,310 $139,546
2020 19 803 945 $317,943 $85,451
Total Patients
4,326
Total Services
5,222
Medicare Billing
$506,105
Procedure Codes
83

All Medicare Procedures & Services

83 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 255 320 $91,113 $31,241 34.3%
66984 Removal of cataract with insertion of prosthetic lens Facility 2023 50 69 $148,452 $30,626 20.6%
66982 Complex removal of cataract with insertion of prosthetic lens Facility 2023 26 31 $89,342 $18,822 21.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 164 183 $36,631 $12,733 34.8%
66821 Removal of recurring cataract in lens capsule using a laser Office 2023 29 34 $44,400 $9,402 21.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 62 62 $28,642 $8,026 28.0%
68761 Closure of tear duct opening using plug Office 2023 32 36 $30,866 $4,870 15.8%
92136 Measurement of corneal curvature and depth of eye Office 2023 85 108 $30,634 $3,976 13.0%
83861 Microfluid analysis of tears Office 2023 87 171 $17,100 $3,767 22.0%
66999 Other procedure on front of eye Facility 2023 13 14 $52,200 $3,536 6.8%
92025 Ct scan of cornea Office 2023 100 109 $21,800 $2,934 13.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 29 30 $8,062 $1,995 24.7%
67999 Other procedure on eyelid Office 2023 11 12 $3,600 $1,646 45.7%
68115 Removal of growth of eyelid lining, more than 1.0 cm Facility 2023 11 14 $6,342 $1,638 25.8%
92134 Imaging of retina Office 2023 31 32 $5,424 $1,092 20.1%
92285 Photography of content of eyes Office 2023 38 41 $6,238 $813.64 13.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 15 15 $3,005 $717.49 23.9%
76512 2d ultrasound scan of eye tissue and structures Office 2023 12 19 $6,612 $643.41 9.7%
92132 Imaging of front third of eye Office 2023 23 25 $3,292 $605.68 18.4%
67820 Removal of eyelashes using forceps Office 2023 16 16 $3,460 $278.98 8.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 282 352 $80,960 $35,074 43.3%
66984 Removal of cataract with insertion of prosthetic lens Facility 2022 43 60 $112,758 $27,458 24.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 144 160 $28,651 $10,978 38.3%
66982 Complex removal of cataract with insertion of prosthetic lens Facility 2022 17 18 $49,966 $10,635 21.3%
68761 Closure of tear duct opening using plug Office 2022 57 70 $58,696 $10,547 18.0%

About Dr. Esen Akpek, M.D

Dr. Esen Akpek, M.D is a Ophthalmology healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851356943.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Esen Akpek, M.D has received a total of $627,113 in payments from pharmaceutical and medical device companies, with $188,970 received in 2024. These payments were reported across 239 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($561,919).

As a Medicare-enrolled provider, Akpek has provided services to 4,326 Medicare beneficiaries, totaling 5,222 services with total Medicare billing of $506,105. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.

Practice Information

  • Specialty Ophthalmology
  • Location Baltimore, MD
  • Active Since 04/20/2006
  • Last Updated 04/06/2015
  • Taxonomy Code 207W00000X
  • Entity Type Individual
  • NPI Number 1851356943

Products in Payments

  • Product in Development (Device) $470,876
  • DUPIXENT (Biological) $39,310
  • XIIDRA (Drug) $20,742
  • DUPIXENT DUPILUMAB INJECTION (Biological) $16,208
  • NO PRODUCT DISCUSSED (Drug) $6,448
  • ACTHAR (Biological) $3,700
  • TEPEZZA (Biological) $2,500
  • Oxervate (Drug) $2,400
  • CEQUA (cyclosporine ophthalmic solution) 0.09% (Drug) $1,569
  • VEVYE (Drug) $1,400
  • OXERVATE (Drug) $600.00
  • BOTOX (Biological) $126.40
  • Clareon (Device) $51.93
  • DEXTENZA (Drug) $50.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Ophthalmology Doctors in Baltimore